micro RNA‐122 regulates hypoxia‐inducible factor‐1 and vimentin in hepatocytes and correlates with fibrosis in diet‐induced steatohepatitis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background & Aims: miR‐122 is the most abundant mi RNA in the liver particularly in hepatocytes where it targets cholesterol metabolism. Steatosis, a key component of non‐alcoholic fatty liver disease, is regulated by hypoxia‐inducible factor‐1α (HIF‐1α). Here, we hypothesized that reduced miR‐122 has a pathogenic role in steatohepatitis. Methods: miR‐122 and its target genes were evaluated in mouse livers and/or isolated hepatocytes after methionine–choline‐deficient (MCD) or methionine–choline‐supplemented (MCS) diet. Results: Liver and hepatocyte miR‐122 expression was significantly decreased in steatohepatitis. A maximum reduction in miR‐122 occurred at the fibrosis stage (8 weeks of MCD diet). MAP 3K3, a miR‐122 target gene, was induced at all stages of non‐alcoholic steatohepatitis (NASH; 3–8 weeks) only at the m RNA level. Increased NF‐κB activation was found in MCD diet‐fed mice and MAP 3K3 regulated the NF‐κB DNA binding in naive hepatocytes. HIF‐1α m RNA and DNA binding and expression of the HIF‐1α target gene, profibrotic lysyl oxidase, was increased in advanced steatohepatitis (8 weeks). In addition, increase in vimentin and Sirius red staining (liver fibrosis) was found at 8 weeks of MCD diet. Using miR‐122 overexpression and inhibition approaches, we confirmed that HIF‐1α, vimentin and MAP 3K3 are novel miR‐122 targets in hepatocytes. We report transcriptional repression of miR‐122 in NASH. Decreased liver miR‐122 was associated with elevated circulating miR‐122 in both exosome‐rich and protein‐rich serum fractions. Conclusions: Our novel data suggest that decreased liver miR‐122 contributes to upregulation of modulators of tissue remodelling (HIF‐1α, vimentin and MAP 3K3) and might play a role in NASH‐induced liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082 · cited 3×
“In addition to cholesterol and fatty acid metabolism (6, 7), miR-122 has several other potential targets.”
Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue
Halberg, N., Khan, T., Trujillo, M. E., Wernstedt-Asterholm, I., Attie, A. D., Sherwani, S., Wang, Z. V., Landskroner-Eiger, S., Dineen, S., Magalang, U. J., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00192-09 · Cited by 896
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645 · cited 1×
“Primary murine hepatocytes were isolated by enzymebased tissue digestion method as described previously (25) and detailed in the Data S1.”
Self-citationFailure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601300 · Cited by 235
Copple, B. L. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02205.x · Cited by 164
Liu, Y., Liu, Y., Yan, X., Xu, Y., Luo, F., Ye, J., Yan, H., Yang, X., Huang, X., Zhang, J., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2056-0 · Cited by 37 · cited 5×
“Furthermore, HIF-1a positively correlates with the expression of the mesenchymal marker vimentin in HCC (24).”
Influential
Cited by
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
Nonalcoholic fatty liver disease
Brunt, E. M., Wong, V. W.-S., Nobili, V., Day, C. P., Sookoian, S., Maher, J. J., Bugianesi, E., Sirlin, C. B., Neuschwander-Tetri, B. A., & Rinella, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.80 · Cited by 818
Exosomes as miRNA Carriers: Formation–Function–Future
Yu, X., Odenthal, M., & Fries, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122028 · Cited by 436
NAFLD in children: new genes, new diagnostic modalities and new drugs
Nobili, V., Alisi, A., Valenti, L., Miele, L., Feldstein, A. E., & Alkhouri, N. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0169-z · Cited by 309
Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
Wang, H., Lu, Z., & Zhao, X. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0806-6 · Cited by 262
The crosstalk: exosomes and lipid metabolism
Wang, W., Zhu, N., Yan, T., Shi, Y.-N., Chen, J., Zhang, C.-J., Xie, X.-J., Liao, D.-F., & Qin, L. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00581-2 · Cited by 203
The role of microRNAs in liver injury at the crossroad between hepatic cell death and regeneration
Lauschke, V. M., Mkrtchian, S., & Ingelman-Sundberg, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.084 · Cited by 29
Huebbe, P., Bilke, S., Rueter, J., Schloesser, A., Campbel, G., Glüer, C.-C., Lucius, R., Röcken, C., Tholey, A., & Rimbach, G. (2024) · Aging and disease · doi:10.14336/ad.2023.0530 · Cited by 24
Alcoholic Liver Disease Accelerates Early Hepatocellular Cancer in a Mouse Model
Szabo, G. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-98788-0_5 · Cited by 4
Metadata
- Authors
- Csak, T., Bala, S., Lippai, D., Satishchandran, A., Catalano, D., Kodys, K., & Szabo, G.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2014-07-28
- Volume
- 35
- Issue
- 2
- Pages
- 532-541
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2033857297
- Cited by
- 128
- References
- 6
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.